Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz

Jared Holz, Mizuho healthcare sector specialist, joins ‘Fast Money’ to discuss Merck’s lawsuit against the federal government over Medicare drug pricing.